Stay updated on Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.

Latest updates to the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page
- CheckyesterdayChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. This is a small UI/metadata change with no impact on core content.SummaryDifference0.7%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference24%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check44 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference5%
Stay in the know with updates to Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.